MétaCan
Menu
Back to cohort
Record W2765702346 · doi:10.1080/15622975.2017.1375556

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

2017· review· en· W2765702346 on OpenAlexfundno aff
Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant, Marcel M. Verbeek, Bruno Dubois, Pieter Jelle Visser, K. A. Jellinger, Sebastiaan Engelborghs, Alfredo Ramı́rez, Lucilla Parnetti, Clifford R. Jack, Charlotte E. Teunissen, Harald Hampel, Alberto Lleó, Frank Jessen, Lidia Glodzik, Mony J. de Leon, Anne M. Fagan, José Luís Molinuevo, Willemijn J. Jansen, Bengt Winblad, Leslie M. Shaw, Ulf Andréasson, Markus Otto, Brit Mollenhauer, Jens Wiltfang, Martin R. Turner, Inga Zerr, Ron Handels, Alexander G. Thompson, Gunilla Johansson, Natalia Ermann, John Q. Trojanowski, Ilker Karaca, Holger Wagner, Patrick Oeckl, Linda van Waalwijk van Doorn, Maria Bjerke, Dimitrios Kapogiannis, H. Bea Kuiperij, Lucia Farotti, Yi Li, Brian A. Gordon, Stéphane Epelbaum, Stephanie J. B. Vos, Catharina J.M. Klijn, William E. Van Nostrand, Carolina Minguillón, Matthias Schmitz, Carla Gallo, Andrea Lopez Mato, Florence Thibaut, Simone Lista, Daniel Alcolea, Henrik Zetterberg, Kaj Blennow, Johannes Kornhuber

Bibliographic record

VenueThe World Journal of Biological Psychiatry · 2017
Typereview
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsnot available
FundersNational Institute on AgingEuropean Brain CouncilInstituto de Salud Carlos IIINational Institutes of HealthFujirebio EuropeRobert Koch InstitutStony Brook UniversityEuropean CommissionFondation pour la Recherche sur AlzheimerVlaamse regeringInnovative Medicines InitiativeRadboud Universitair Medisch CentrumFonds Wetenschappelijk OnderzoekBundesministerium für GesundheitHartstichtingEuropean Regional Development FundInternationale Stichting Alzheimer OnderzoekDeutsche Parkinson VereinigungUniversité Pierre et Marie CurieBundesministerium für Bildung und ForschungAXA Research FundBiogenAgence Nationale de la RechercheRoyal Swedish Academy of SciencesMotor Neurone Disease AssociationOryzon GenomicsKoch Institute for Integrative Cancer Research, Massachusetts Institute of TechnologyAlzheimer's AssociationEuropean Federation of Pharmaceutical Industries and AssociationsPfizerEU Joint Programme – Neurodegenerative Disease ResearchKrajowy Naukowy Osrodek WiodacyYork UniversityNational Institute of Neurological Disorders and StrokeDeutsches Zentrum für Neurodegenerative ErkrankungenUniversidade de AveiroNational Research CentreMassachusetts General HospitalMedical Research CouncilLeids Universitair Medisch CentrumBristol-Myers SquibbTeva Pharmaceutical IndustriesCohen Veterans BioscienceDeutsche ForschungsgemeinschaftGlaxoSmithKlineEli Lilly and CompanyUniversiteit AntwerpenZonMwMichael J. Fox Foundation for Parkinson's Research
KeywordsDementiaModalitiesBiobankNeuroimagingPositron emission tomographyDiseaseMedicineBiological fluidsTask forceMedical physicsPsychologyIntensive care medicineNeuroscienceData sciencePsychiatryPathologyBioinformaticsComputer sciencePolitical scienceBiology

Abstract

fetched live from OpenAlex

In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and update the original paper. New concepts of Alzheimer's disease (AD) and the conceptual interactions between AD and dementia due to AD were developed, resulting in two sets for diagnostic/research criteria. Procedures for pre-analytical sample handling, biobanking, analyses and post-analytical interpretation of the results were intensively studied and optimised. A global quality control project was introduced to evaluate and monitor the inter-centre variability in measurements with the goal of harmonisation of results. Contexts of use and how to approach candidate biomarkers in biological specimens other than cerebrospinal fluid (CSF), e.g. blood, were precisely defined. Important development was achieved in neuroimaging techniques, including studies comparing amyloid-β positron emission tomography results to fluid-based modalities. Similarly, development in research laboratory technologies, such as ultra-sensitive methods, raises our hopes to further improve analytical and diagnostic accuracy of classic and novel candidate biomarkers. Synergistically, advancement in clinical trials of anti-dementia therapies energises and motivates the efforts to find and optimise the most reliable early diagnostic modalities. Finally, the first studies were published addressing the potential of cost-effectiveness of the biomarkers-based diagnosis of neurodegenerative disorders.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.074
metaresearch head score (Gemma)0.046
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.074
Threshold uncertainty score0.390

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0740.046
Meta-epidemiology (narrow)0.0030.001
Meta-epidemiology (broad)0.0050.003
Bibliometrics0.0110.008
Science and technology studies0.0020.004
Scholarly communication0.0060.006
Open science0.0060.005
Research integrity0.0080.010
Insufficient payload (model declined to judge)0.0010.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.088
GPT teacher head0.378
Teacher spread0.290 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations318
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueThe World Journal of Biological PsychiatrySame topicAlzheimer's disease research and treatmentsFrench-language works237,207